Barch, Deanna M <br/><br/>
Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations.  [electronic resource] 

 -  Biological psychiatry  Jul 2011 
 - 13-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-2402 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2011.01.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Brain Mapping--methods<br/>Cognition Disorders--complications<br/>Humans<br/>Nootropic Agents--therapeutic use<br/>Psychometrics--methods<br/>Reproducibility of Results<br/>Research Design--standards<br/>Schizophrenia--complications